Advancing Global Health
Gilead recognizes that the development of innovative medicines for life-threatening diseases is only one aspect of improving public health. We also invest in programs that promote prevention, strengthen healthcare infrastructure, and provide education and financial support to the most vulnerable communities around the world.
By enabling access to medicines, challenging assumptions, fighting stigma and collaborating with partners worldwide, we work not simply to treat some of the world’s most challenging public health threats – but to eliminate them
Expanding Treatment Access in Low- and Middle-Income Countries
Gilead is committed to meeting with public health officials, doctors and patients around the world to understand barriers and opportunities related to HIV, viral hepatitis and visceral leishmaniasis (VL)
Helping Eliminate Chronic Hepatitis C Worldwide
The WHO has set the goal of eliminating viral hepatitis worldwide by 2030. Through awareness, screening and care, we’re helping governments, patients and payers in efforts to eliminate the chronic hepatitis C virus (HCV) and eradicate the disease.
Keeping Girls and Young Women HIV-Free in Sub-Saharan Countries
Gilead partners with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to help reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries.